UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

  

FORM 8-K  

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 25, 2017 

 

 

 

PhaseRx, Inc.

(Exact name of registrant as specified in its charter) 

 

Delaware 001-37772 20-4690620
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer Identification No.)

 

410 W. Harrison Street, Suite 300
Seattle, Washington
98119
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (206) 805-6300

  

 

 

(Former name or former address, if changed since last report)

  

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☒

  

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 25, 2017, PhaseRx, Inc. (the “Company”) appointed Robert W. Overell, who currently serves as the Company’s president and chief executive officer, as the Company’s principal accounting officer, effective as of the same date. Biographical and compensation information for Dr. Overell are included in the Company’s definitive proxy statement for the 2017 Annual Meeting of Stockholders and are incorporated herein by reference.

  

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PhaseRx, Inc.
     
Date: September 26, 2017 By: /s/ Robert W. Overell
    Robert W. Overell, Ph.D.
    Chief Executive Officer

 

 

 

 

 

PhaseRx (CE) (USOTC:PZRXQ)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more PhaseRx (CE) Charts.
PhaseRx (CE) (USOTC:PZRXQ)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more PhaseRx (CE) Charts.